One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Editor’s Choice – John Ingram – Oct 2023
doi : 10.1093/bjd/ljad289
British Journal of Dermatology, Volume 189, Issue 4, October 2023, Pages i–ii
New insights into programmed cell death protein 1 blockade-associated cutaneous immune-related adverse events
Goran Micevic ,1,2 Andrew Daniels2 and Richard A. Flavell2
doi : 10.1093/bjd/ljad236
The expanding psoriasis therapeutic landscape: reading and understanding clinical trials
Niamh Kearney 1,2 and Brian Kirby
doi : 10.1093/bjd/ljad238
Seeking new topical therapies in psoriasis
Dominika Kwiatkowska and Adam Reich
doi : 10.1093/bjd/ljad233
Promising results for treatment of severe chronic hand eczema with dupilumab
Richard Brans
doi : 10.1093/bjd/ljad199
Heterogeneity of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia
Tsen-Fang Tsai
doi : 10.1093/bjd/ljad197
Predicting progression in very thin melanoma: the challenge of the next decade?
Simone Ribero, Pietro Quaglino and Gabriele Roccuzzo
doi : 10.1093/bjd/ljad218
A nationwide UK cohort study reveals an association between atopic dermatitis and venous thromboembolism
Chien-Hui Hong1,2 and Chih-Hung Lee
doi : 10.1093/bjd/ljad221
Validation of a new measure of patient global assessment in psoriasis
Charlotte E. Gollins 1,2 and Laura C. Coates
doi : 10.1093/bjd/ljad228
The interleukin-1 pathway as a treatment target in early-stage hidradenitis suppurativa?
Ina Suhrkamp and Sascha Gerdes
doi : 10.1093/bjd/ljad225
More than skin deep: getting on the same page for mental health in children and young people with skin conditions
Hsi Yen 1,2,3 and Yvonne E. Chiu 3,
doi : 10.1093/bjd/ljad232
Major adverse cardiovascular events in patients with atopic dermatitis treated with oral Janus kinase inhibitors: a systematic review and meta-analysis
Cécile Ertus,1 Lucie-Marie Scailteux,2,3 Alain Lescoat ,2,4 Pauline Berthe,1 Vincent Auffret ,5 Alain Dupuy ,2,3 Emmanuel Oger 2,3 and Catherine Droitcourt
doi : 10.1093/bjd/ljad229
Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment
Sascha Gerdes,1 Petra Staubach,2 Thomas Dirschka,3 Dieter Wetzel,4 Oliver Weirich,5 Johannes Niesmann,6 Rodrigo da Mota,7 Alex Rothhaar,8 Michael Ardabili,9 Gerda Vlasitz,10 Joachim Feldwisch,10 Lisa Osterling Koskinen,10 Sven Ohlman,10 Paul M. Peloso,11 Nikolai C. Brun10 and Fredrik Y. Frejd
doi : 10.1093/bjd/ljad186
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study
Leon H. Kircik,1,2,3,4 Javier Alonso-Llamazares,5 Neal Bhatia,6 Michael Bukhalo,7 Alim R. Devani,8,9,10 Zoe D. Draelos,11 Janet DuBois,12 Melinda J. Gooderham,13,14,15 Steven E. Kempers,16 Edward Lain,17 Mark Lee,18 Angela Moore,19,20 Dedee F. Murrell ,21 Kim A. Papp ,22,23 David M. Pariser,24,25 Rodney Sinclair,26 Matthew Zirwas,27,28 Patrick Burnett,29 Robert C. Higham,29 David Krupa29 and David R. Berk
doi : 10.1093/bjd/ljad182
Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study
Angelique N. Voorberg ,1 Esmé Kamphuis ,1 Wietske A. Christoffers 2 and Marie L.A. Schuttelaar
doi : 10.1093/bjd/ljad156
Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020
Siew Eng Choon ,1,2 Alison K. Wright,3 Christopher E.M. Griffiths,4,5 Kit Wan Wong,1,2 Kwee Eng Tey,1,2 Yee Ting Lim,1,2 Keow Yin Chua1,2 and Darren M. Ashcroft3; on behalf of the Global Psoriasis Atlas
doi : 10.1093/bjd/ljad158
Predictors of sentinel lymph node metastasis in very thin invasive melanomas
Hanna Kakish ,1 James Sun,1 David X. Zheng,2 Fasih Ali Ahmed,1 Mohamedraed Elshami,1 Alexander W. Loftus,1 Lee M. Ocuin,1 John B. Ammori,1 Richard S. Hoehn,1 Jeremy S. Bordeaux2 and Luke D. Rothermel
doi : 10.1093/bjd/ljad195
The risk of venous thromboembolism in atopic dermatitis: a matched cohort analysis in UK primary care
Richard B. Warren ,1,2 Victoria Basey,3 Anita Lynam,4 Charlotte Curtis4 and Michael R. Ardern-Jones
doi : 10.1093/bjd/ljad212
Measurement properties of the patient global assessment numerical rating scale in moderate-to-severe psoriasis
Ning Yu,1 Chen Peng,1 Jing Zhou,1 Jun Gu,2 Jinhua Xu,3 Xia Li,4 Xinling Bi,5 Hui Deng,6 Xin Li,7 Yangfeng Ding1 and Yuling Shi
doi : 10.1093/bjd/ljad188
Targeting the NLRP3 inflammasome reduces inflammation in hidradenitis suppurativa skin
Barry Moran,1 Conor M. Smith ,1 Alexandra Zaborowski,2 Mark Ryan,3 Jozsef Karman,4 Robert W. Dunstan,3 Kathleen M. Smith,4 Roisin Hambly,5 Jana Musilova,6 Andreea Petrasca ,1 Aurelie Fabre,7 Margaret O’Donnell,8 Karsten Hokamp,9 Kingston H.G. Mills,1 William J. Housley,3 Desmond C. Winter,2 Brian Kirby 5 and Jean M. Fletcher
doi : 10.1093/bjd/ljad184
British Society for Paediatric and Adolescent Dermatology assessment and support of mental health in children and young people with skin conditions: a multidisciplinary expert consensus statement and recommendations
Tess McPherson ,1 Jane Ravenscroft ,2,3 Rukshana Ali,4 Richard Barlow,5 Paula Beattie,6 Anthony Bewley,7,8 Sophie Bennett,9 Tanya Bleiker,10 Liz Buckley,11 Gary Burgess,9 Sarah Copperwheat,12 Tim Cunliffe,13 Hannah Dejong,1 Mina Fazel,14,15 Isobel Heyman,9 Emma Howard,4 Alice Lambert,16 Claire Manktelow,17 Zahra Moledina ,18 Padma Mohandas,7 Celia Moss ,19 Guy Northover,20 Isabel Paz,14,21 Andrew Proctor,16 Christine Roxborough,22 Shatha Shibib,23 Lea Solman,9 Jo Srinivasan,11 Damian Wood11 and Susannah Baron4; on behalf of British Society of Paediatric and Adolescent Dermatology (BSPAD) mental health consensus recommendation development group (CRDG)
doi : 10.1093/bjd/ljad193
Has the time come to assess small-molecule/biologic drug combinations for the management of moderate-to-severe hidradenitis suppurativa?
Carlo Alberto Maronese ,1,2 John R. Ingram 3 and Angelo V. Marzano
doi : 10.1093/bjd/ljad224
The top 10 research priorities for the treatment of bullous pemphigoid, mucous membrane pemphigoid and pemphigus vulgaris in the UK: results of a James Lind Alliance Priority Setting Partnership
Karen E. Harman,1,2 Jag Barha,3 Jo R. Chalmers,1 John K.G. Dart ,4,5 Isobel Davies,3 Patricia Ellis,6 Douglas Grindlay ,1 Philip J. Hampton ,7 Sharleen Hill,8 Sharon Hockey,3 Antonia Lloyd-Lavery ,9 Maggie McPhee,1 Ruth Murphy ,10 Saaeha Rauz ,11,12 Jane F. Setterfield ,13,14 Ingrid Thompson,3 Melanie Westmoreland 9 and Christina Waistell
doi : 10.1093/bjd/ljad140
Sarcomatoid transformation of a basal cell carcinoma following treatment with hedgehog inhibitors
Cristina Barrabés-Torrella ,1 Jorge Arandes-Marcocci,1 Lucia Armillas-Lliteras,1 Rodolfo A. Posada-Caez,1 Inessa Koptseva,1 Caterina Fumagalli,2 David Pi?ol-Ball?s2 and Montse Salleras-Redonnet
doi : 10.1093/bjd/ljad206
Allergen-specific IgG4 increase in atopic dermatitis with long-term dupilumab use
Mariko Ogawa-Momohara, Yoshinao Muro, Chiaki Murase, Tomoki Taki , Kana Tanahashi, Yuta Yamashita, Haruka Koizumi , Ryo Fukaura, Takuya Takeichi and Masashi Akiyama
doi : 10.1093/bjd/ljad207
Agreement and reliability of remote assessment of actinic keratosis: a proof-of-concept study using smartphone photographs
Vinzent Kevin Ortner,1 John R. Zibert,2,3 Ionela Manole,2,4 Alejandro Castillo Mondrag?n,2 Anders Daniel Andersen2 and Merete Haedersdal
doi : 10.1093/bjd/ljad209
Postoperative adjuvant therapy for 120Â patients with melanoma, including acral and mucosal subtypes: a multicentre, observational study of 2-year follow-up results
Yusuke Muto,1 Yumi Kambayashi,1 Hiroshi Kato,2 Satoshi Fukushima,3 Takamichi Ito,4 Takeo Maekawa,5 Ishizuki Shoichiro,6 Hiroshi Uchi,7 Shigeto Matsushita,8 Yuki Yamamoto,9 Koji Yoshino,10 Yasuhiro Fujisawa,11 Ryo Amagai,1 Kentaro Ohuchi,1 Akira Hashimoto,1 Yoshihide Asano1 and Taku Fujimura
doi : 10.1093/bjd/ljad183
Gender disparity in Canadian Institutes of Health Research grant funding decisions among recipients from dermatology departments: a retrospective study
Brendan Tao ,1 Jeffrey Ding ,1 Marissa Joseph ,2 Chi-Wei Tien ,1 Sahil Chawla ,1 Waleed Khan,3 and Faisal Khosa
doi : 10.1093/bjd/ljad192
Use of direct microscopy to diagnose superficial mycoses: a survey of UK dermatology practice
David J. Chandler ,1,2 Reika Yamamoto1 and Rod J. Hay
doi : 10.1093/bjd/ljad213
No evidence of isotretinoin sensitization in peanut-allergic children: a cross-sectional study
Emma Ruth ,1 Fionnuala Heraghty,1 Niamh Flynn,1 Triona McGlynn,1 Paul J. Turner ,2 Maeve Kelleher ,1 Aideen Byrne 1,3 and Jonathan O’B. Hourihane 1,4
doi : 10.1093/bjd/ljad214
Mogamulizumab-induced bone granuloma: a multicentre nationwide case series
Florent Amatore,1 Delphine Darbord,2 Nathalie Franck,2 Agnes Carlotti,3 Baptiste Gillet,3 Aurelie Haffner,4 Stephanie Coze,5 Emmanuel Delaporte,1 Ana Carrasquilla-Capilla,6 Stephane Dalle6 and Olivier Dereure
doi : 10.1093/bjd/ljad210
High-grade cervical squamous intraepithelial lesions in female partners of men with high-grade penile squamous intraepithelial lesions: a monocentric retrospective study
Camille Isnard,1 Johan Chanal,1,2 Christine Bergeron3 and Olivier Aynaud
doi : 10.1093/bjd/ljad211
Bidirectional Mendelian randomization analysis did not indicate a causal relationship between atopic dermatitis and COVID-19
Min Luo, Changhua Zhu, Jinger Lin, Lihang Lin and Yue Han
doi : 10.1093/bjd/ljad208
Autoimmune, inflammatory, allergic and neuropsychiatric outcomes of offspring born to mothers with vitiligo: a nationwide Korean population-based birth cohort study
Ju Hee Han ,1 Hyun Jeong Ju ,2 Hyun Kang ,3 Ji Hae Lee ,2 Solam Lee 3 and Jung Min Bae
doi : 10.1093/bjd/ljad196
Use of the Dermatology Life Quality Index suite of patient-reported outcome measures in skin-related neglected tropical diseases
Muhammad H. Junejo ,1 Isabella Wolfe,1 Jaina Patel,2 Emma Duus,2 Oluwatobiloba Oyebanji,2 and Stephen L. Walker
doi : 10.1093/bjd/ljad217
Systemic immunosuppressive therapies for children with refractory atopic dermatitis: a large real-life cohort study
Ayelet Ollech ,1,4 Rachel Lefferdink,2 Anjani Sheth,2 Alli Blumstein,2 Divya Ramachandran,2 Anette Wagner,1,2,3 Brandi Kenner-Bell,1,2,3 Anthony J. Mancini,1,2,3 Sarah Chamlin,1,2,3 Lacey L. Kruse,1,2,3 Stephanie M. Rangel2 and Amy S. Paller
doi : 10.1093/bjd/ljad222
Reporting of Harmonising Outcome Measures for Eczema (HOME) core outcome set instruments in randomized clinical trials for systemic treatments in atopic dermatitis
Megan Lam ,1 Phyllis I. Spuls ,2 Yael A. Leshem ,3 Louise A.A. Gerbens ,2 Kim S. Thomas ,4 Bernd Arents ,5 Tim Burton,6 Carsten Flohr 7 and Aaron M. Drucker
doi : 10.1093/bjd/ljad237
A qualitative exploration of patient experiences in pyoderma gangrenosum
Samantha Herbert , Reneé Haughton , William Liakos , Jenny Wang , Antonio Ji-Xu , Stephanie T. Le and Emanual Maverakis
doi : 10.1093/bjd/ljad235
Melanonychia as a manifestation of chronic lead poisoning
Patrizia Elva Aguilar-Calder?n , Mayra A. Reyes-Soto, Emmanuel S?nchez-Meza, Alejandra Brown-Herrera, Jorge Ocampo-Candiani and Luc?a T. Fern?ndez
doi : 10.1093/bjd/ljad194
A review of major adverse cardiovascular events in patients with atopic dermatitis treated with oral Janus kinase inhibitors
doi : 10.1093/bjd/ljad296
The risk of deep-vein blood clots in people with atopic dermatitis (eczema)
doi : 10.1093/bjd/ljad294
Eleven recommendations to support mental health in children and young people with skin conditions
doi : 10.1093/bjd/ljad298
